Kenodol Tablet
Ketorolac Tromethamine 10 m
Product Key Facts
Analgesic & Anti-inflammatory
Medications that help alleviate pain and reduce inflammation in the body.
Pain and Inflammation Relief
Pain and inflammation relief aims to alleviate discomfort and swelling caused by injuries, arthritis, infections, or chronic conditions. It involves using medications or natural remedies to reduce pain and promote healing.
Details at a Glance
| Product Code | : | 1631 |
| Pack Size | : | 2x10's |
| MRP | : | ৳ 240 |
Specifications
KENODOL® 10 mg Tablet: Each box contains 2 x 10 Tablets in Alu-Alu pack. KENODOL® 30 mg Injection: Each box contains 1 Ampoule of 1 ml in Alu-Pvc pack. KENODOL® 60 mg Injection: Each box contains 1 Ampoule of 2 ml in Alu-Pvc pack.
KENODOL® (Ketorolac Tromethamine) is indicated for the short-term management of moderate to moderately severe acute pain, including post-surgical pain (such as general, orthopaedic and dental surgery), acute musculoskeletal trauma pain and post-partum uterine cramping pain.
Dosage should be adjusted according to the severity of the pain and the response of the patient. Injection: When administering Ketorolac injection, the IV bolus must be given over no less than 15 seconds. The IM administration should be given slowly and deeply into the muscle. The analgesic effect begins in ~30 minutes with maximum effect in 1 to 2 hours after dosing IV or IM. Duration of analgesic effect is usually 4 to 6 hours. Single dose administration: IV dosing - patients < 65 years of age: 30 mg/day and patients > 65 years of age, renally impaired and/or less than 50 kg of body weight: 15 mg/day. IM dosing - patients < 65 years of age: 60 mg/day and patients > 65 years of age, renally impaired and/or less than 50 kg of body weight: 30 mg/day. Multiple dose administration: Patients < 65 years of age: 30 mg every 6 hours. The maximum daily dose should not exceed 120 mg and patients > 65 years of age, renally impaired and/or less than 50 kg of body weight: 15 mg every 6 hours. The maximum daily dose should not exceed 60 mg. Tablet: The usual oral dose of Ketorolac Tromethamine is 10 mg every 4 to 6 hours as required. Doses exceeding 40 mg per day are not recommended. For patients receiving Ketorolac injections, and who are converted to Ketorolac oral tablets, the total combined daily dose should not exceed 90 mg ( 60 mg for the elderly, renally-impaired patients and patients less than 50 kg) and the oral component should not exceed 40 mg on the day the change of formulation is made. Patients should be converted to oral treatment as soon as possible.
